Breast cancer cells can switch between estrogen receptor α and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance

✍ Scribed by Katrine Sonne-Hansen; Ida C. Norrie; Kristina B. Emdal; Rikke V. Benjaminsen; Thomas Frogne; Ib J. Christiansen; Tove Kirkegaard; Anne E. Lykkesfeldt

• Book ID: 106378370
• Publisher: Springer US
• Year: 2009
• Tongue: English
• Weight: 521 KB
• Volume: 121
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-009-0506-y